ATE352785T1 - Verfahren zum nachweis von hepatitis c antigenen - Google Patents
Verfahren zum nachweis von hepatitis c antigenenInfo
- Publication number
- ATE352785T1 ATE352785T1 AT00952184T AT00952184T ATE352785T1 AT E352785 T1 ATE352785 T1 AT E352785T1 AT 00952184 T AT00952184 T AT 00952184T AT 00952184 T AT00952184 T AT 00952184T AT E352785 T1 ATE352785 T1 AT E352785T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatitis
- antigens
- detecting hepatitis
- virus
- detecting
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000010836 blood and blood product Substances 0.000 abstract 1
- 229940125691 blood product Drugs 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14607999P | 1999-07-28 | 1999-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE352785T1 true ATE352785T1 (de) | 2007-02-15 |
Family
ID=22515775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00952184T ATE352785T1 (de) | 1999-07-28 | 2000-07-25 | Verfahren zum nachweis von hepatitis c antigenen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1295126B1 (de) |
JP (2) | JP5498637B2 (de) |
AT (1) | ATE352785T1 (de) |
CA (1) | CA2380777C (de) |
CY (1) | CY1106349T1 (de) |
DE (1) | DE60033190T2 (de) |
DK (1) | DK1295126T3 (de) |
ES (1) | ES2279766T3 (de) |
PT (1) | PT1295126E (de) |
WO (1) | WO2001009609A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0702183D0 (en) * | 2007-02-05 | 2007-03-14 | Iti Scotland Ltd | Pathogen binding |
FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
CN105209616A (zh) | 2013-03-14 | 2015-12-30 | 雅培制药有限公司 | 用于改进的抗体检测的hcv ns3重组抗原及其突变体 |
US9194873B2 (en) | 2013-03-14 | 2015-11-24 | Abbott Laboratories | HCV antigen-antibody combination assay and methods and compositions for use therein |
EP3916103A1 (de) | 2013-03-14 | 2021-12-01 | Abbott Laboratories | Monoklonale antikörper gegen hcv-core lipid-bindender domäne |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464474A (en) * | 1980-07-09 | 1984-08-07 | Connaught Laboratories Limited | Non-A, non-B hepatitis assay and vaccine |
FR2502154A1 (fr) * | 1981-03-30 | 1982-09-24 | Trepo Christian | Procede de preparation d'antigenes de l'hepatite virale nanb, et application a la realisation d'un reactif permettant le diagnostic et le pronostic des infections provoquees par les virus des hepatites virales |
US5308750A (en) * | 1989-12-22 | 1994-05-03 | Abbott Laboratories | Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same |
EP0569537B1 (de) * | 1991-01-31 | 1998-06-17 | Abbott Laboratories | Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen |
WO1993006488A1 (en) * | 1991-09-16 | 1993-04-01 | Genelabs Technologies, Inc. | Peptide based hepatitis c virus immunoassays |
UA39944C2 (uk) * | 1992-07-07 | 2001-07-16 | Чірон Корпорейшн | Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі |
GB9214877D0 (en) * | 1992-07-14 | 1992-08-26 | Smith Meters Ltd | Dry gas meter |
JPH06327482A (ja) * | 1993-05-21 | 1994-11-29 | Imuno Japan:Kk | オリゴペプタイド、オリゴヌクレオチドならびにc型肝炎ウ イルス関連抗体検出方法 |
US6747136B2 (en) * | 1996-04-19 | 2004-06-08 | Karolinska Innovations Ab | Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
AU9497998A (en) * | 1997-09-22 | 1999-04-12 | Chiron Corporation | Method for detecting antibodies in a sample |
-
2000
- 2000-07-25 DK DK00952184T patent/DK1295126T3/da active
- 2000-07-25 CA CA2380777A patent/CA2380777C/en not_active Expired - Lifetime
- 2000-07-25 ES ES00952184T patent/ES2279766T3/es not_active Expired - Lifetime
- 2000-07-25 PT PT00952184T patent/PT1295126E/pt unknown
- 2000-07-25 WO PCT/US2000/020214 patent/WO2001009609A2/en active IP Right Grant
- 2000-07-25 AT AT00952184T patent/ATE352785T1/de active
- 2000-07-25 DE DE60033190T patent/DE60033190T2/de not_active Expired - Lifetime
- 2000-07-25 JP JP2001514569A patent/JP5498637B2/ja not_active Expired - Lifetime
- 2000-07-25 EP EP00952184A patent/EP1295126B1/de not_active Expired - Lifetime
-
2007
- 2007-03-01 CY CY20071100291T patent/CY1106349T1/el unknown
-
2009
- 2009-12-02 JP JP2009275000A patent/JP2010048830A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1295126A2 (de) | 2003-03-26 |
CA2380777A1 (en) | 2001-02-08 |
WO2001009609A3 (en) | 2003-01-09 |
ES2279766T3 (es) | 2007-09-01 |
WO2001009609A2 (en) | 2001-02-08 |
JP5498637B2 (ja) | 2014-05-21 |
JP2010048830A (ja) | 2010-03-04 |
DE60033190T2 (de) | 2007-10-31 |
DK1295126T3 (da) | 2007-04-10 |
CA2380777C (en) | 2011-01-04 |
CY1106349T1 (el) | 2011-10-12 |
PT1295126E (pt) | 2007-03-30 |
EP1295126B1 (de) | 2007-01-24 |
DE60033190D1 (de) | 2007-03-15 |
JP2003529744A (ja) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE376187T1 (de) | Nachweis von erkrankungen der nieren und behandlung | |
DE60013287D1 (de) | Früherkennung der flaviviren unter verwendung des ns1-glycoproteins | |
ATE446745T1 (de) | Antikörper mit t-zell-rezeptor-artiger spezifität,aber höherer affinität und seine verwendung zum nachweis und zur behandlung von krebs, virusinfektionen und autoimmunkrankheiten | |
FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
EP0914155A4 (de) | Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen | |
ATE118275T1 (de) | Immunoassayverfahren zum nachweis von antigenen. | |
DE60110256D1 (de) | Verfahren zum konzentrieren von analyten in proben | |
DE59007613D1 (de) | Verfahren zum Nachweis und zur Bestimmung von Humanserumalbumin in biologischen Flüssigkeiten mit Hilfe fluorogener Cyanin-Farbstoffe. | |
DE68923605D1 (de) | Immunodiagnostisches Verfahren zum Nachweis und zur Bestimmung von Euterentzündung. | |
EP0248534A3 (de) | Verfahren zum Nachweis einer AIDS-Virus-Infektion | |
ATE397215T1 (de) | Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind | |
ATE352785T1 (de) | Verfahren zum nachweis von hepatitis c antigenen | |
ATE191568T1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
ATE105086T1 (de) | Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b. | |
ATE112392T1 (de) | Agglutinationskomplex zum nachweis von blutgruppen. | |
ATE539350T1 (de) | Verfahren zum nachweis oder zum bestimmen von hbv | |
ATE132268T1 (de) | Immuntest zum gleichzeitigen nachweis von hiv-1, hiv-2, htlv-i und htlv-ii antikörpern | |
ATE367582T1 (de) | Verfahren zum nachweis von borna-disease-virus (bdv)- infektionen | |
CA2095735A1 (en) | Monoclonal antibodies to hepatitis c virus and method for using same | |
DK0513227T3 (da) | Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens | |
GR3029320T3 (en) | Monoclonal antibodies to putative hcv ns5 proteins and methos for using same. | |
DE3853315D1 (de) | Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens. | |
DE3783840D1 (de) | Verfahren zur bestimmung von plasma-protein und testsatz dafuer. | |
DE58902996D1 (de) | Verfahren zum nachweis von antikoerpern gegen erythrozytenspezifische antigene. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1295126 Country of ref document: EP |